Page last updated: 2024-11-01

nevirapine and Bile Duct Diseases

nevirapine has been researched along with Bile Duct Diseases in 1 studies

Nevirapine: A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS.
nevirapine : A dipyridodiazepine that is 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepine which is substituted by methyl, oxo, and cyclopropyl groups at positions 4, 6, and 11, respectively. A non-nucleoside reverse transcriptase inhibitor with activity against HIV-1, it is used in combination with other antiretrovirals for the treatment of HIV infection.

Bile Duct Diseases: Diseases in any part of the ductal system of the BILIARY TRACT from the smallest BILE CANALICULI to the largest COMMON BILE DUCT.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kochar, R1
Nevah, MI1
Lukens, FJ1
Fallon, MB1
Machicao, VI1

Other Studies

1 other study available for nevirapine and Bile Duct Diseases

ArticleYear
Vanishing bile duct syndrome in human immunodeficiency virus: nevirapine hepatotoxicity revisited.
    World journal of gastroenterology, 2010, Jul-14, Volume: 16, Issue:26

    Topics: Adult; Anti-HIV Agents; Bile Duct Diseases; Bile Ducts, Intrahepatic; Cholestasis, Intrahepatic; Fem

2010